Ballentine Partners’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $352K | Buy |
+886
| New | +$252K | ﹤0.01% | 711 |
|
|
2026
Q1 | – | Sell |
-972
| Closed | -$249K | – | 1056 |
|
|
2025
Q4 | $249K | Sell |
972
-138
| -12% | -$36.2K | ﹤0.01% | 814 |
|
|
2025
Q3 | $289K | Buy |
1,110
+185
| +20% | +$48.6K | ﹤0.01% | 729 |
|
|
2025
Q2 | $226K | Sell |
925
-688
| -43% | -$172K | ﹤0.01% | 827 |
|
|
2025
Q1 | $427K | Sell |
1,613
-51
| -3% | -$13.8K | 0.01% | 495 |
|
|
2024
Q4 | $422K | Sell |
1,664
-4,373
| -72% | -$1.17M | 0.01% | 476 |
|
|
2024
Q3 | $1.91M | Sell |
6,037
-298
| -5% | -$106K | 0.03% | 177 |
|
|
2024
Q2 | $2.37M | Buy |
6,335
+4,926
| +350% | +$1.66M | 0.04% | 139 |
|
|
2024
Q1 | $489K | Sell |
1,409
-1,012
| -42% | -$384K | 0.01% | 393 |
|
|
2023
Q4 | $1.11M | Sell |
2,421
-105
| -4% | -$51.8K | 0.02% | 217 |
|
|
2023
Q3 | $1.23M | Sell |
2,526
-151
| -6% | -$71K | 0.03% | 176 |
|
|
2023
Q2 | $1.2M | Sell |
2,677
-782
| -23% | -$394K | 0.03% | 182 |
|
|
2023
Q1 | $1.68M | Buy |
3,459
+1,755
| +103% | +$868K | 0.04% | 140 |
|
|
2022
Q4 | $873K | Buy |
1,704
+52
| +3% | +$27.3K | 0.03% | 184 |
|
|
2022
Q3 | $801K | Buy |
1,652
+283
| +21% | +$138K | 0.03% | 177 |
|
|
2022
Q2 | $641K | Sell |
1,369
-79
| -5% | -$35.2K | 0.02% | 206 |
|
|
2022
Q1 | $630K | Buy |
1,448
+4
| +0.3% | +$1.67K | 0.02% | 229 |
|
|
2021
Q4 | $670K | Buy |
1,444
+1
| +0.1% | +$443 | 0.02% | 228 |
|
|
2021
Q3 | $561K | Buy |
1,443
+12
| +0.8% | +$5.09K | 0.02% | 221 |
|
|
2021
Q2 | $633K | Buy |
1,431
+1
| +0.1% | +$437 | 0.02% | 204 |
|
|
2021
Q1 | $600K | Sell |
1,430
-99
| -6% | -$39.5K | 0.02% | 201 |
|
|
2020
Q4 | $627K | Sell |
1,529
-202
| -12% | -$84K | 0.02% | 189 |
|
|
2020
Q3 | $690K | Buy |
1,731
+7
| +0.4% | +$2.82K | 0.03% | 169 |
|
|
2020
Q2 | $668K | Sell |
1,724
-4
| -0.2% | -$1.5K | 0.03% | 182 |
|
|
2020
Q1 | $542K | Sell |
1,728
-39
| -2% | -$13.2K | 0.03% | 181 |
|
|
2019
Q4 | $648K | Buy |
1,767
+16
| +0.9% | +$5.08K | 0.03% | 195 |
|
|
2019
Q3 | $448K | Buy |
1,751
+42
| +2% | +$11.8K | 0.02% | 222 |
|
|
2019
Q2 | $453K | Sell |
1,709
-9
| -0.5% | -$2.28K | 0.02% | 225 |
|
|
2019
Q1 | $457K | Buy |
1,718
+101
| +6% | +$29.1K | 0.02% | 200 |
|
|
2018
Q4 | $463K | Buy |
1,617
+27
| +2% | +$8.56K | 0.03% | 192 |
|
|
2018
Q3 | $538K | Buy |
1,590
+17
| +1% | +$5.52K | 0.03% | 190 |
|
|
2018
Q2 | $469K | Sell |
1,573
-6
| -0.4% | -$1.76K | 0.03% | 194 |
|
|
2018
Q1 | $425K | Buy |
1,579
+134
| +9% | +$36.3K | 0.02% | 204 |
|
|
2017
Q4 | $359K | Buy |
1,445
+22
| +2% | +$5.43K | 0.02% | 239 |
|
|
2017
Q3 | $347K | Buy |
1,423
+23
| +2% | +$5.63K | 0.02% | 244 |
|
|
2017
Q2 | $329K | Buy |
1,400
+192
| +16% | +$43.5K | 0.02% | 255 |
|
|
2017
Q1 | $249K | Buy |
+1,208
| New | +$250K | 0.02% | 205 |
|
Other funds holding HUM
HGIM
PL
FFM
CNB
WC
II
COPPSERS
P
Ballentine Partners's HUM Position: Q2 2026 in Review
Ballentine Partners opened a new position in Humana (HUM) in Q2 2026: 886 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #711 among its holdings. This is a return to the name: Ballentine Partners previously reported a position in HUM as recently as Q4 2025.
Ballentine Partners first reported a position in HUM in Q1 2017 and has held it in 37 quarters since. The position peaked at $2.37M in Q2 2024. 171 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Ballentine Partners held 886 shares of Humana worth $352K as of Q2 2026.
- Humana was a new Ballentine Partners position in Q2 2026.
- Humana made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #711 holding.
- Ballentine Partners first reported a position in Humana in Q1 2017 and has held it in 37 quarters since.
- Ballentine Partners's Humana position peaked at $2.37M in Q2 2024.
- 171 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.